Telmisartan Improves Insulin Resistance in Patients With Low Cytokine Levels

Metabolic syndrome (MS) is a disease with an inflammatory component. Telmisartan improves insulin resistance in MS, but its relationship with the inflammatory state is unknown. We investigated the effect of 3-month telmisartan therapy on homeostatic model assessment-insulin resistance (HOMA-IR) in h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of investigative medicine 2011-03, Vol.59 (3), p.602-605
Hauptverfasser:	Sanchez Muñoz-Torrero, Juan Francisco, Rivas, Maria D., Costo, Alberto, Crespo, Leandro, Fraile, Juana, Doncel, Carlos, Fernandez Toro, Jose Maria, Zamorano, Jose
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Benzimidazoles - pharmacology Benzimidazoles - therapeutic use Benzoates - pharmacology Benzoates - therapeutic use Biomarkers - blood Blood Glucose - drug effects Blood Glucose - metabolism Cytokines - blood Female Humans Hypertension - blood Hypertension - drug therapy Insulin resistance Insulin Resistance - physiology Male Metabolic Syndrome - blood Metabolic Syndrome - drug therapy Middle Aged
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!